{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:46:13Z","timestamp":1790721973914,"version":"4.1.0"},"reference-count":415,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The emergence of the COVID-19 pandemic made it critical to understand the immune and inflammatory responses to the SARS-CoV-2 virus. It became increasingly recognized that the immune response was a key mediator of illness severity and that its mechanisms needed to be better understood. Early infection of both tissue and immune cells, such as macrophages, leading to pyroptosis-mediated inflammasome production in an organ system critical for systemic oxygenation likely plays a central role in the morbidity wrought by SARS-CoV-2. Delayed transcription of Type I and Type III interferons by SARS-CoV-2 may lead to early disinhibition of viral replication. Cytokines such as interleukin-1 (IL-1), IL-6, IL-12, and tumor necrosis factor \u03b1 (TNF\u03b1), some of which may be produced through mechanisms involving nuclear factor kappa B (NF-\u03baB), likely contribute to the hyperinflammatory state in patients with severe COVID-19. Lymphopenia, more apparent among natural killer (NK) cells, CD8+ T-cells, and B-cells, can contribute to disease severity and may reflect direct cytopathic effects of SARS-CoV-2 or end-organ sequestration. Direct infection and immune activation of endothelial cells by SARS-CoV-2 may be a critical mechanism through which end-organ systems are impacted. In this context, endovascular neutrophil extracellular trap (NET) formation and microthrombi development can be seen in the lungs and other critical organs throughout the body, such as the heart, gut, and brain. The kidney may be among the most impacted extrapulmonary organ by SARS-CoV-2 infection owing to a high concentration of ACE2 and exposure to systemic SARS-CoV-2. In the kidney, acute tubular injury, early myofibroblast activation, and collapsing glomerulopathy in select populations likely account for COVID-19-related AKI and CKD development. The development of COVID-19-associated nephropathy (COVAN), in particular, may be mediated through IL-6 and signal transducer and activator of transcription 3 (STAT3) signaling, suggesting a direct connection between the COVID-19-related immune response and the development of chronic disease. Chronic manifestations of COVID-19 also include systemic conditions like Multisystem Inflammatory Syndrome in Children (MIS-C) and Adults (MIS-A) and post-acute sequelae of\u00a0COVID-19 (PASC), which may reflect a spectrum of clinical presentations of persistent immune dysregulation. The lessons learned and those undergoing continued study likely have broad implications for understanding viral infections\u2019 immunologic and inflammatory consequences beyond coronaviruses.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1376654","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T07:28:46Z","timestamp":1739345326000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Immunologic and inflammatory consequences of SARS-CoV-2 infection and its implications in renal disease"],"prefix":"10.3389","volume":"15","author":[{"given":"Hiam","family":"Naiditch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Betts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Benjamin","family":"Larman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi Z.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v91i1.9397","article-title":"WHO declares COVID-19 a pandemic","volume":"91","author":"Cucinotta","year":"2020","journal-title":"Acta Biomed"},{"key":"B2","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/d41586-020-02416-z","article-title":"How we accelerated clinical trials in the age of coronavirus","volume":"584","author":"Mather","year":"2020","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2171","article-title":"The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus","volume":"31","author":"Wu","year":"2021","journal-title":"Rev Med Virol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000023315","article-title":"Association of elevated inflammatory markers and severe COVID-19: A meta-analysis","volume":"99","author":"Ji","year":"2020","journal-title":"Med (Baltimore)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41581-020-00357-4","article-title":"Immunity, endothelial injury and complement-induced coagulopathy in COVID-19","volume":"17","author":"Perico","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2028436","article-title":"Safety and immunogenicity of SARS-coV-2 mRNA-1273 vaccine in older adults","volume":"383","author":"Anderson","year":"2020","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00542-x","article-title":"Neutralizing monoclonal antibodies for treatment of COVID-19","volume":"21","author":"Taylor","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 M(pro) inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2116044","article-title":"Molnupiravir for oral treatment of covid-19 in nonhospitalized patients","volume":"386","author":"Jayk Bernal","year":"2022","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.21064","article-title":"COVID-19: multisystem inflammatory syndrome in children (MIS-C)","volume":"14","author":"Aldawas","year":"2022","journal-title":"Cureus"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s12098-021-03832-3","article-title":"Multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19 infection","volume":"88","author":"Kashyap","year":"2021","journal-title":"Indian J Pediatr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.3390\/microorganisms9071393","article-title":"Multisystem inflammatory syndrome in an adult (MIS-A) successfully treated with anakinra and glucocorticoids","volume":"9","author":"Cattaneo","year":"2021","journal-title":"Microorganisms"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.26456","article-title":"Clinical characteristics of multisystem inflammatory syndrome in adults: A systematic review","volume":"4","author":"Patel","year":"2021","journal-title":"JAMA Netw Open"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.3390\/cells10123592","article-title":"New onset of autoimmune diseases following COVID-19 diagnosis","volume":"10","author":"Gracia-Ramos","year":"2021","journal-title":"Cells"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1038\/s41467-021-22781-1","article-title":"Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection","volume":"12","author":"Diao","year":"2021","journal-title":"Nat Commun"},{"key":"B17","doi-asserted-by":"publisher","first-page":"7634","DOI":"10.1038\/s41467-022-35297-z","article-title":"Single-cell profiling of healthy human kidney reveals features of sex-based transcriptional programs and tissue-specific immunity","volume":"13","author":"McEvoy","year":"2022","journal-title":"Nat Commun"},{"key":"B18","doi-asserted-by":"publisher","first-page":"15678","DOI":"10.1038\/s41598-020-72821-x","article-title":"Immune cell composition in normal human kidneys","volume":"10","author":"Park","year":"2020","journal-title":"Sci Rep"},{"key":"B19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.stem.2021.12.010","article-title":"SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids","volume":"29","author":"Jansen","year":"2022","journal-title":"Cell Stem Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41467-021-27723-5","article-title":"Postmortem high-dimensional immune profiling of severe COVID-19 patients reveals distinct patterns of immunosuppression and immunoactivation","volume":"13","author":"Wu","year":"2022","journal-title":"Nat Commun"},{"key":"B21","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41392-021-00792-0","article-title":"Myeloid cells in COVID-19 microenvironment","volume":"6","author":"Qin","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","volume":"19","author":"V\u2019Kovski","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e0252721","DOI":"10.1128\/mBio.02527-21","article-title":"Infectious SARS-coV-2 is emitted in aerosol particles","volume":"12","author":"Hawks","year":"2021","journal-title":"mBio"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.1038\/s41467-020-17367-2","article-title":"SARS-CoV-2 is transmitted via contact and via the air between ferrets","volume":"11","author":"Richard","year":"2020","journal-title":"Nat Commun"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2015482118","article-title":"Mechanistic transmission modeling of COVID-19 on the Diamond Princess cruise ship demonstrates the importance of aerosol transmission","volume":"118","author":"Azimi","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","article-title":"SARS-coV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues","volume":"181","author":"Ziegler","year":"2020","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s12041-021-01262-w","article-title":"Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19","volume":"100","author":"Senapati","year":"2021","journal-title":"J Genet"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-021-01006-7","article-title":"Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease","volume":"54","author":"Horowitz","year":"2022","journal-title":"Nat Genet"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-021-00985-x","article-title":"Understanding COVID-19 through genome-wide association studies","volume":"54","author":"Karlsen","year":"2022","journal-title":"Nat Genet"},{"key":"B32","doi-asserted-by":"publisher","first-page":"101213","DOI":"10.1016\/j.diabet.2020.11.005","article-title":"DPP-4 inhibition and COVID-19: From initial concerns to recent expectations","volume":"47","author":"Scheen","year":"2021","journal-title":"Diabetes Metab"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.3390\/molecules25112529","article-title":"In silico evaluation of the effectivity of approved protease inhibitors against the main protease of the novel SARS-coV-2 virus","volume":"25","author":"Eleftheriou","year":"2020","journal-title":"Molecules"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-020-0688-y","article-title":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses","volume":"5","author":"Letko","year":"2020","journal-title":"Nat Microbiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12882-022-02747-1","article-title":"Regulation of SARS CoV-2 host factors in the kidney and heart in rats with 5\/6 nephrectomy-effects of salt, ARB, DPP4 inhibitor and SGLT2 blocker","volume":"23","author":"Xiong","year":"2022","journal-title":"BMC Nephrol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"5392","DOI":"10.3390\/molecules25225392","article-title":"A novel purification procedure for active recombinant human DPP4 and the inability of DPP4 to bind SARS-coV-2","volume":"25","author":"Xi","year":"2020","journal-title":"Molecules"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-021-02092-0","article-title":"Glycosylation is a key in SARS-CoV-2 infection","volume":"99","author":"Reis","year":"2021","journal-title":"J Mol Med (Berl)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00713-0","article-title":"SARS-coV-2 pathogenesis","volume":"20","author":"Lamers","year":"2022","journal-title":"Nat Rev Microbiol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab686","article-title":"Severe acute respiratory syndrome coronavirus 2 viremia is associated with coronavirus disease 2019 severity and predicts clinical outcomes","volume":"74","author":"Jacobs","year":"2022","journal-title":"Clin Infect Dis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-023-00878-2","article-title":"The evolution of SARS-coV-2","volume":"21","author":"Markov","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3390\/microorganisms10030501","article-title":"Innate immune response in SARS-coV-2 infection","volume":"10","author":"Schiuma","year":"2022","journal-title":"Microorganisms"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2021.05.004","article-title":"Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19","volume":"29","author":"Lowery","year":"2021","journal-title":"Cell Host Microbe"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2021.62.5.381","article-title":"Roles of type I and III interferons in COVID-19","volume":"62","author":"Choi","year":"2021","journal-title":"Yonsei Med J"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-micro-092611-150203","article-title":"A virological view of innate immune recognition","volume":"66","author":"Iwasaki","year":"2012","journal-title":"Annu Rev Microbiol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/v3060920","article-title":"Pattern recognition receptors and the innate immune response to viral infection","volume":"3","author":"Thompson","year":"2011","journal-title":"Viruses"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.13719","article-title":"Presence of genetic variants among young men with severe COVID-19","volume":"324","author":"van der Made","year":"2020","journal-title":"JAMA"},{"key":"B47","doi-asserted-by":"publisher","first-page":"103642","DOI":"10.1016\/j.ebiom.2021.103642","article-title":"Off balance: Interferons in COVID-19 lung infections","volume":"73","author":"Akamatsu","year":"2021","journal-title":"EBioMedicine"},{"key":"B48","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/nri2358","article-title":"Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases","volume":"8","author":"Gilliet","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.3390\/microorganisms9091820","article-title":"TLR3 and TLR7 RNA sensor activation during SARS-coV-2 infection","volume":"9","author":"Bortolotti","year":"2021","journal-title":"Microorganisms"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.05.002","article-title":"Immunology of COVID-19: current state of the science","volume":"52","author":"Vabret","year":"2020","journal-title":"Immunity"},{"key":"B51","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1084\/jem.20131314","article-title":"MyD88-dependent interplay between myeloid and endothelial cells in the initiation and progression of obesity-associated inflammatory diseases","volume":"211","author":"Yu","year":"2014","journal-title":"J Exp Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"631879","DOI":"10.3389\/fphar.2021.631879","article-title":"SARS-coV-2 switches \u2018on\u2019 MAPK and NFkappaB signaling via the reduction of nuclear DUSP1 and DUSP5 expression","volume":"12","author":"Goel","year":"2021","journal-title":"Front Pharmacol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41392-020-00334-0","article-title":"SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation","volume":"5","author":"Li","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.3389\/fimmu.2017.01220","article-title":"Induction of apoptosis and subsequent phagocytosis of virus-infected cells as an antiviral mechanism","volume":"8","author":"Nainu","year":"2017","journal-title":"Front Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"706252","DOI":"10.3389\/fcimb.2021.706252","article-title":"SARS-coV-2 membrane glycoprotein M triggers apoptosis with the assistance of nucleocapsid protein N in cells","volume":"11","author":"Ren","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00011-020-01413-2","article-title":"Inflammasome formation in the lungs of patients with fatal COVID-19","volume":"70","author":"Toldo","year":"2021","journal-title":"Inflamm Res"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.3390\/cells11101717","article-title":"Pyroptosis and its role in SARS-coV-2 infection","volume":"11","author":"Bittner","year":"2022","journal-title":"Cells"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-021-00916-7","article-title":"SARS-CoV-2 non-structural protein 6 triggers NLRP3-dependent pyroptosis by targeting ATP6AP1","volume":"29","author":"Sun","year":"2022","journal-title":"Cell Death Differ"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.3389\/fimmu.2019.02275","article-title":"Editorial: alveolar macrophages in lung inflammation and resolution","volume":"10","author":"Hu","year":"2019","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41392-022-00892-5","article-title":"NK cell dysfunction in severe COVID-19: TGF-beta-induced downregulation of integrin beta-2 restricts NK cell cytotoxicity","volume":"7","author":"Barros-Martins","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.3390\/molecules27072048","article-title":"Angiotensin II type I receptor (AT1R): the gate towards COVID-19-associated diseases","volume":"27","author":"El-Arif","year":"2022","journal-title":"Molecules"},{"key":"B62","doi-asserted-by":"publisher","first-page":"636966","DOI":"10.3389\/fimmu.2021.636966","article-title":"Endocytosis and transcytosis of SARS-coV-2 across the intestinal epithelium and other tissue barriers","volume":"12","author":"Knyazev","year":"2021","journal-title":"Front Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s41232-020-00146-3","article-title":"How COVID-19 induces cytokine storm with high mortality","volume":"40","author":"Hojyo","year":"2020","journal-title":"Inflammation Regen"},{"key":"B64","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-kappaB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct Target Ther"},{"key":"B65","doi-asserted-by":"crossref","first-page":"108255","DOI":"10.1016\/j.intimp.2021.108255","article-title":"The triumvirate of NF-kappaB, inflammation and cytokine storm in COVID-19","volume":"101","author":"Attiq","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.10.6504","article-title":"Airway epithelium controls lung inflammation and injury through the NF-kappa B pathway","volume":"178","author":"Cheng","year":"2007","journal-title":"J Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41420-021-00428-w","article-title":"SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes","volume":"7","author":"Ferreira","year":"2021","journal-title":"Cell Death Discovery"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201707","article-title":"Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients","volume":"218","author":"Rodrigues","year":"2021","journal-title":"J Exp Med"},{"key":"B69","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.3390\/v13122418","article-title":"Single-cell and bulk RNASeq profiling of COVID-19 patients reveal immune and inflammatory mechanisms of infection-induced organ damage","volume":"13","author":"Bass","year":"2021","journal-title":"Viruses"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S258639","article-title":"Role of monocytes\/macrophages in covid-19 pathogenesis: implications for therapy","volume":"13","author":"Gomez-Rial","year":"2020","journal-title":"Infect Drug Resist"},{"key":"B71","doi-asserted-by":"publisher","first-page":"720109","DOI":"10.3389\/fimmu.2021.720109","article-title":"Monocytes and macrophages in COVID-19","volume":"12","author":"Knoll","year":"2021","journal-title":"Front Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"108652","DOI":"10.1016\/j.clim.2020.108652","article-title":"Influenza infection, SARS, MERS and COVID-19: Cytokine storm - The common denominator and the lessons to be learned","volume":"223","author":"Ryabkova","year":"2021","journal-title":"Clin Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2022.0029","article-title":"Comparing the cytokine storms of COVID-19 and pandemic influenza","volume":"42","author":"Pacheco-Hernandez","year":"2022","journal-title":"J Interferon Cytokine Res"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.3313","article-title":"Is a \u201cCytokine storm\u201d Relevant to COVID-19","volume":"180","author":"Sinha","year":"2020","journal-title":"JAMA Intern Med"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.140329","article-title":"Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections","volume":"5","author":"Remy","year":"2020","journal-title":"JCI Insight"},{"key":"B76","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12985-022-01814-1","article-title":"COVID-19 infection: an overview on cytokine storm and related interventions","volume":"19","author":"Montazersaheb","year":"2022","journal-title":"Virol J"},{"key":"B77","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.drudis.2021.10.016","article-title":"Calming the cytokine storm of COVID-19 through inhibition of JAK2\/STAT3 signaling","volume":"27","author":"Gajjela","year":"2022","journal-title":"Drug Discovery Today"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01500-9","article-title":"Calming the cytokine storm in COVID-19","volume":"27","author":"Cron","year":"2021","journal-title":"Nat Med"},{"key":"B79","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jaci.2020.04.027","article-title":"Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19","volume":"146","author":"Yang","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2020.1770129","article-title":"Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors","volume":"9","author":"Han","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"B81","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12879-022-07079-x","article-title":"Comparison of cytokines levels among COVID-19 patients living at sea level and high altitude","volume":"22","author":"Del Valle-Mendoza","year":"2022","journal-title":"BMC Infect Dis"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00901-9","article-title":"Lessons learned: new insights on the role of cytokines in COVID-19","volume":"22","author":"Buszko","year":"2021","journal-title":"Nat Immunol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"629193","DOI":"10.3389\/fimmu.2021.629193","article-title":"SARS-coV-2 causes a different cytokine response compared to other cytokine storm-causing respiratory viruses in severely ill patients","volume":"12","author":"Olbei","year":"2021","journal-title":"Front Immunol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"e0427","DOI":"10.1097\/CCE.0000000000000427","article-title":"Is microthrombosis the main pathology in coronavirus disease 2019 severity?-A systematic review of the postmortem pathologic findings","volume":"3","author":"Fahmy","year":"2021","journal-title":"Crit Care Explor"},{"key":"B85","doi-asserted-by":"publisher","first-page":"7092","DOI":"10.1038\/s41467-021-27318-0","article-title":"Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2","volume":"12","author":"Hatton","year":"2021","journal-title":"Nat Commun"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2021.0060","article-title":"Control of innate immune activation by severe acute respiratory syndrome coronavirus 2 and other coronaviruses","volume":"41","author":"Kehrer","year":"2021","journal-title":"J Interferon Cytokine Res"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: a complex web of host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01122-w","article-title":"The T cell immune response against SARS-CoV-2","volume":"23","author":"Moss","year":"2022","journal-title":"Nat Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc8665","article-title":"Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2","volume":"369","author":"Thoms","year":"2020","journal-title":"Science"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.05.008","article-title":"Type I and type III interferons - induction, signaling, evasion, and application to combat COVID-19","volume":"27","author":"Park","year":"2020","journal-title":"Cell Host Microbe"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00211-10","article-title":"Murine coronavirus delays expression of a subset of interferon-stimulated genes","volume":"84","author":"Rose","year":"2010","journal-title":"J Virol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.03535-14","article-title":"The nsp1, nsp13, and M proteins contribute to the hepatotropism of murine coronavirus JHM","volume":"89","author":"Zhang","year":"2015","journal-title":"WU. J Virol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science"},{"key":"B95","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.immuni.2021.01.017","article-title":"Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity","volume":"54","author":"Hoagland","year":"2021","journal-title":"Immunity"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01114-w","article-title":"Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules","volume":"23","author":"Stravalaci","year":"2022","journal-title":"Nat Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2010540117","article-title":"Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients","volume":"117","author":"Holter","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa1103","article-title":"C-reactive protein and clinical outcomes in patients with COVID-19","volume":"42","author":"Smilowitz","year":"2021","journal-title":"Eur Heart J"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04802-1","article-title":"Inflammasome activation in infected macrophages drives COVID-19 pathology","volume":"606","author":"Sefik","year":"2022","journal-title":"Nature"},{"key":"B100","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41577-020-0317-2","article-title":"Macrophages: a trojan horse in COVID-19","volume":"20","author":"Park","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.3389\/fimmu.2020.01312","article-title":"The lung macrophage in SARS-coV-2 infection: A friend or a foe","volume":"11","author":"Abassi","year":"2020","journal-title":"Front Immunol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"683800","DOI":"10.3389\/fimmu.2021.683800","article-title":"SARS-coV-2\/ACE2 interaction suppresses IRAK-M expression and promotes pro-inflammatory cytokine production in macrophages","volume":"12","author":"Pantazi","year":"2021","journal-title":"Front Immunol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa356","article-title":"Attenuated interferon and proinflammatory response in SARS-coV-2-infected human dendritic cells is associated with viral antagonism of STAT1 phosphorylation","volume":"222","author":"Yang","year":"2020","journal-title":"J Infect Dis"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.add4906","article-title":"Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-induced cytokine storm during COVID-19","volume":"7","author":"Laurent","year":"2022","journal-title":"Sci Immunol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12915-017-0392-4","article-title":"Tissue macrophages: heterogeneity and functions","volume":"15","author":"Gordon","year":"2017","journal-title":"BMC Biol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"100013","DOI":"10.1016\/j.immuno.2022.100013","article-title":"Association of pyroptosis and severeness of COVID-19 as revealed by integrated single-cell transcriptome data analysis","volume":"6","author":"Xu","year":"2022","journal-title":"Immunoinformatics (Amst)"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-05-023770","article-title":"Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon","volume":"109","author":"Cervantes-Barragan","year":"2007","journal-title":"Blood"},{"key":"B108","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/s41467-023-36140-9","article-title":"Severe COVID-19 patients have impaired plasmacytoid dendritic cell-mediated control of SARS-CoV-2","volume":"14","author":"Venet","year":"2023","journal-title":"Nat Commun"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00728-2","article-title":"Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection","volume":"18","author":"Perez-Gomez","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.4VMR1114-555R","article-title":"Neutrophils in viral infections: Current concepts and caveats","volume":"98","author":"Galani","year":"2015","journal-title":"J Leukoc Biol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-021-00805-z","article-title":"Patients with COVID-19: in the dark-NETs of neutrophils","volume":"28","author":"Ackermann","year":"2021","journal-title":"Cell Death Differ"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern Med"},{"key":"B113","doi-asserted-by":"publisher","first-page":"21519","DOI":"10.1038\/s41598-021-00927-x","article-title":"Prognostic value of neutrophil-to-lymphocyte ratio in COVID-19 compared with Influenza and respiratory syncytial virus infection","volume":"11","author":"Prozan","year":"2021","journal-title":"Sci Rep"},{"key":"B114","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1016\/j.jinf.2020.04.002","article-title":"Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19","volume":"81","author":"Liu","year":"2020","journal-title":"J Infect"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.cell.2020.08.001","article-title":"Severe COVID-19 is marked by a dysregulated myeloid cell compartment","volume":"182","author":"Schulte-Schrepping","year":"2020","journal-title":"Cell"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-022-03068-w","article-title":"Emergency myelopoiesis in critical illness: lessons from the COVID-19 pandemic","volume":"192","author":"O\u2019Driscoll","year":"2022","journal-title":"Ir J Med Sci"},{"key":"B117","doi-asserted-by":"publisher","first-page":"19630","DOI":"10.1038\/s41598-020-76781-0","article-title":"The emerging role of neutrophil extracellular traps in severe acute respiratory syndrome coronavirus 2 (COVID-19)","volume":"10","author":"Arcanjo","year":"2020","journal-title":"Sci Rep"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science"},{"key":"B119","doi-asserted-by":"publisher","first-page":"95","DOI":"10.5114\/ceji.2022.113078","article-title":"NK cells in SARS-CoV-2 infection","volume":"47","author":"Pituch-Noworolska","year":"2022","journal-title":"Cent Eur J Immunol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"108186","DOI":"10.1016\/j.celrep.2020.108186","article-title":"Coordinated viral control by cytotoxic lymphocytes ensures optimal adaptive NK cell responses","volume":"32","author":"Diaz-Salazar","year":"2020","journal-title":"Cell Rep"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abd6832","article-title":"Natural killer cell immunotypes related to COVID-19 disease severity","volume":"5","author":"Maucourant","year":"2020","journal-title":"Sci Immunol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2021.06.005","article-title":"Natural killer cells and unconventional T cells in COVID-19","volume":"49","author":"Bjorkstrom","year":"2021","journal-title":"Curr Opin Virol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1002\/art.39295","article-title":"Inhibition of natural killer cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome","volume":"67","author":"Cifaldi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ajpath.2020.08.009","article-title":"Immunopathology of hyperinflammation in COVID-19","volume":"191","author":"Gustine","year":"2021","journal-title":"Am J Pathol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"aaa6566","DOI":"10.1126\/science.aaa6566","article-title":"Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology","volume":"348","author":"Eberl","year":"2015","journal-title":"Science"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.74681","article-title":"Innate lymphoid cells and COVID-19 severity in SARS-CoV-2 infection","volume":"11","author":"Silverstein","year":"2022","journal-title":"Elife"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abd7114","article-title":"Comprehensive mapping of immune perturbations associated with severe COVID-19","volume":"5","author":"Kuri-Cervantes","year":"2020","journal-title":"Sci Immunol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3390\/v13020241","article-title":"Mucosal-associated invariant T (MAIT) cells are highly activated and functionally impaired in COVID-19 patients","volume":"13","author":"Deschler","year":"2021","journal-title":"Viruses"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00870-z","article-title":"Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity","volume":"22","author":"Flament","year":"2021","journal-title":"Nat Immunol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0191-y","article-title":"Mucosal-associated invariant T cells and disease","volume":"19","author":"Toubal","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0271463","article-title":"SARS-CoV-2 spike and nucleocapsid proteins fail to activate human dendritic cells or gammadelta T cells","volume":"17","author":"Singh","year":"2022","journal-title":"PloS One"},{"key":"B132","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3390\/vaccines9060562","article-title":"Lymphopenia in COVID-19: gammadelta T cells-based therapeutic opportunities","volume":"9","author":"Lo Presti","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B133","doi-asserted-by":"publisher","first-page":"741218","DOI":"10.3389\/fimmu.2021.741218","article-title":"Gamma delta T cells and their involvement in COVID-19 virus infections","volume":"12","author":"von Massow","year":"2021","journal-title":"Front Immunol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1080\/1040841X.2020.1822279","article-title":"Making a case for using gammadelta T cells against SARS-CoV-2","volume":"46","author":"Yazdanifar","year":"2020","journal-title":"Crit Rev Microbiol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1086\/502975","article-title":"Anti-severe acute respiratory syndrome coronavirus immune responses: the role played by V gamma 9V delta 2 T cells","volume":"193","author":"Poccia","year":"2006","journal-title":"J Infect Dis"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15620","article-title":"The phenotypic changes of gammadelta T cells in COVID-19 patients","volume":"24","author":"Lei","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.01.007","article-title":"Adaptive immunity to SARS-coV-2 and COVID-19","volume":"184","author":"Sette","year":"2021","journal-title":"Cell"},{"key":"B138","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41392-020-0148-4","article-title":"Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study","volume":"5","author":"Tan","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"B139","doi-asserted-by":"publisher","first-page":"108590","DOI":"10.1016\/j.celrep.2020.108590","article-title":"Cell-type-specific immune dysregulation in severely ill COVID-19 patients","volume":"34","author":"Yao","year":"2021","journal-title":"Cell Rep"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","volume":"26","author":"Gupta","year":"2020","journal-title":"Nat Med"},{"key":"B141","doi-asserted-by":"publisher","first-page":"661052","DOI":"10.3389\/fimmu.2021.661052","article-title":"SARS-coV-2 induces lymphocytopenia by promoting inflammation and decimates secondary lymphoid organs","volume":"12","author":"Xiang","year":"2021","journal-title":"Front Immunol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40560-020-00453-4","article-title":"Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis","volume":"8","author":"Huang","year":"2020","journal-title":"J Intensive Care"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B144","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front Immunol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.cell.2020.10.001","article-title":"Imbalance of regulatory and cytotoxic SARS-coV-2-reactive CD4(+) T cells in COVID-19","volume":"183","author":"Meckiff","year":"2020","journal-title":"Cell"},{"key":"B146","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-coV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"B147","doi-asserted-by":"publisher","first-page":"108728","DOI":"10.1016\/j.celrep.2021.108728","article-title":"Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients","volume":"34","author":"Tan","year":"2021","journal-title":"Cell Rep"},{"key":"B148","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.cell.2020.09.038","article-title":"Antigen-specific adaptive immunity to SARS-coV-2 in acute COVID-19 and associations with age and disease severity","volume":"183","author":"Rydyznski Moderbacher","year":"2020","journal-title":"Cell"},{"key":"B149","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","article-title":"Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19","volume":"183","author":"Sekine","year":"2020","journal-title":"Cell"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.5COVA0720-421RR","article-title":"Regulatory CD4(+) and CD8(+) T cells are negatively correlated with CD4(+)\/CD8(+) T cell ratios in patients acutely infected with SARS-CoV-2","volume":"109","author":"Gao","year":"2021","journal-title":"J Leukoc Biol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cell.2020.08.025","article-title":"Loss of bcl-6-expressing T follicular helper cells and germinal centers in COVID-19","volume":"183","author":"Kaneko","year":"2020","journal-title":"Cell"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2012.01112.x","article-title":"Roles of BCL6 in normal and transformed germinal center B cells","volume":"247","author":"Basso","year":"2012","journal-title":"Immunol Rev"},{"key":"B153","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ajpath.2012.03.044","article-title":"Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies","volume":"181","author":"Maddur","year":"2012","journal-title":"Am J Pathol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00553-8","article-title":"Is IL-6 a key cytokine target for therapy in COVID-19","volume":"21","author":"Jones","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.3390\/cells10061550","article-title":"The role of th17 response in COVID-19","volume":"10","author":"Martonik","year":"2021","journal-title":"Cells"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.30047","article-title":"Th17 and Treg cells function in SARS-CoV2 patients compared with healthy controls","volume":"236","author":"Sadeghi","year":"2021","journal-title":"J Cell Physiol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00750-4","article-title":"Activation or exhaustion of CD8(+) T cells in patients with COVID-19","volume":"18","author":"Rha","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B158","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.immuni.2021.04.009","article-title":"CD8(+) T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity","volume":"54","author":"Nguyen","year":"2021","journal-title":"Immunity"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-00557-9","article-title":"Unique immunological profile in patients with COVID-19","volume":"18","author":"Varchetta","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B160","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1038\/s41467-020-17240-2","article-title":"Immunological and inflammatory profiles in mild and severe cases of COVID-19","volume":"11","author":"Song","year":"2020","journal-title":"Nat Commun"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc8511","article-title":"Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications","volume":"369","author":"Mathew","year":"2020","journal-title":"Science"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04186-8","article-title":"Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2","volume":"601","author":"Swadling","year":"2022","journal-title":"Nature"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.179","article-title":"Macrophage activation syndrome in the era of biologic therapy","volume":"12","author":"Grom","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"B164","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1038\/s41467-021-24377-1","article-title":"SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells","volume":"12","author":"Jung","year":"2021","journal-title":"Nat Commun"},{"key":"B165","doi-asserted-by":"publisher","first-page":"110214","DOI":"10.1016\/j.celrep.2021.110214","article-title":"Recruitment of highly cytotoxic CD8(+) T cell receptors in mild SARS-CoV-2 infection","volume":"38","author":"Wagner","year":"2022","journal-title":"Cell Rep"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04280-x","article-title":"Signature of long-lived memory CD8(+) T cells in acute SARS-CoV-2 infection","volume":"602","author":"Adamo","year":"2022","journal-title":"Nature"},{"key":"B167","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1016\/j.cell.2020.11.019","article-title":"The identity of human tissue-emigrant CD8(+) T cells","volume":"183","author":"Buggert","year":"2020","journal-title":"Cell"},{"key":"B168","doi-asserted-by":"publisher","first-page":"ofab143","DOI":"10.1093\/ofid\/ofab143","article-title":"CD8+ T-cell responses in COVID-19 convalescent individuals target conserved epitopes from multiple prominent SARS-coV-2 circulating variants","volume":"8","author":"Redd","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04460-3","article-title":"T cell responses to SARS-CoV-2 spike cross-recognize Omicron","volume":"603","author":"Keeton","year":"2022","journal-title":"Nature"},{"key":"B170","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nri.2017.106","article-title":"Beyond binding: antibody effector functions in infectious diseases","volume":"18","author":"Lu","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf4063","article-title":"Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection","volume":"371","author":"Dan","year":"2021","journal-title":"Science"},{"key":"B172","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41467-020-20247-4","article-title":"Neutralizing antibody titres in SARS-CoV-2 infections","volume":"12","author":"Lau","year":"2021","journal-title":"Nat Commun"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2021.06.009","article-title":"Antibody and B cell responses to SARS-CoV-2 infection and vaccination","volume":"29","author":"Roltgen","year":"2021","journal-title":"Cell Host Microbe"},{"key":"B174","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3390\/pathogens11020186","article-title":"Formation and expansion of memory B cells against coronavirus in acutely infected COVID-19 individuals","volume":"11","author":"Embong","year":"2022","journal-title":"Pathogens"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1172\/JCI146927","article-title":"Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality","volume":"131","author":"Morgenlander","year":"2021","journal-title":"J Clin Invest"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008556","article-title":"Harnessing the natural anti-glycan immune response to limit the transmission of enveloped viruses such as SARS-CoV-2","volume":"16","author":"Breiman","year":"2020","journal-title":"PloS Pathog"},{"key":"B177","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3390\/v13020160","article-title":"ABO blood types and COVID-19: spurious, anecdotal, or truly important relationships? A reasoned review of available data","volume":"13","author":"Pendu","year":"2021","journal-title":"Viruses"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2020283","article-title":"Genomewide association study of severe covid-19 with respiratory failure","volume":"383","author":"Severe Covid","year":"2020","journal-title":"N Engl J Med"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01042-x","article-title":"Expanded COVID-19 phenotype definitions reveal distinct patterns of genetic association and protective effects","volume":"54","author":"Roberts","year":"2022","journal-title":"Nat Genet"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1016\/j.pulmoe.2021.03.008","article-title":"The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives","volume":"27","author":"Boechat","year":"2021","journal-title":"Pulmonology"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-00814-z","article-title":"Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19","volume":"21","author":"Woodruff","year":"2020","journal-title":"Nat Immunol"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0897-1","article-title":"Antibody responses to SARS-CoV-2 in patients with COVID-19","volume":"26","author":"Long","year":"2020","journal-title":"Nat Med"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abe0367","article-title":"Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients","volume":"5","author":"Iyer","year":"2020","journal-title":"Sci Immunol"},{"key":"B184","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41577-021-00657-1","article-title":"The germinal centre B cell response to SARS-CoV-2","volume":"22","author":"Laidlaw","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04778-y","article-title":"Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost","volume":"607","author":"Muecksch","year":"2022","journal-title":"Nature"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-120419-022408","article-title":"Germinal centers","volume":"40","author":"Victora","year":"2022","journal-title":"Annu Rev Immunol"},{"key":"B187","doi-asserted-by":"publisher","first-page":"109320","DOI":"10.1016\/j.celrep.2021.109320","article-title":"Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4(+) T cell help","volume":"35","author":"Pusnik","year":"2021","journal-title":"Cell Rep"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03647-4","article-title":"SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans","volume":"595","author":"Turner","year":"2021","journal-title":"Nature"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.06.016","article-title":"Long-lived plasma cells are contained within the CD19(-)CD38(hi)CD138(+) subset in human bone marrow","volume":"43","author":"Halliley","year":"2015","journal-title":"Immunity"},{"key":"B190","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41541-021-00369-6","article-title":"Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action","volume":"6","author":"Heinz","year":"2021","journal-title":"NPJ Vaccines"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2027906","article-title":"Safety and immunogenicity of two RNA-based covid-19 vaccine candidates","volume":"383","author":"Walsh","year":"2020","journal-title":"N Engl J Med"},{"key":"B192","doi-asserted-by":"publisher","first-page":"abm0829","DOI":"10.1126\/science.abm0829","article-title":"mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern","volume":"374","author":"Goel","year":"2021","journal-title":"Science"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1126\/science.add2897","article-title":"T cell immunity to COVID-19 vaccines","volume":"377","author":"Wherry","year":"2022","journal-title":"Science"},{"key":"B194","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.cell.2022.03.024","article-title":"Vaccine protection against the SARS-CoV-2 Omicron variant in macaques","volume":"185","author":"Chandrashekar","year":"2022","journal-title":"Cell"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04465-y","article-title":"Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron","volume":"603","author":"Liu","year":"2022","journal-title":"Nature"},{"key":"B196","doi-asserted-by":"publisher","first-page":"19765","DOI":"10.1038\/s41598-020-74988-9","article-title":"Clinical presentations, laboratory and radiological findings, and treatments for 11,028 COVID-19 patients: a systematic review and meta-analysis","volume":"10","author":"Wong","year":"2020","journal-title":"Sci Rep"},{"key":"B197","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.3390\/v13091880","article-title":"Myocardial damage by SARS-coV-2: emerging mechanisms and therapies","volume":"13","author":"Ho","year":"2021","journal-title":"Viruses"},{"key":"B198","doi-asserted-by":"publisher","first-page":"684874","DOI":"10.3389\/fcell.2021.684874","article-title":"The altered anatomical distribution of ACE2 in the brain with alzheimer\u2019s disease pathology","volume":"9","author":"Cui","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B199","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B200","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3390\/jcm10030446","article-title":"Multi-organ involvement in COVID-19: beyond pulmonary manifestations","volume":"10","author":"Thakur","year":"2021","journal-title":"J Clin Med"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20209610","article-title":"The protein expression profile of ACE2 in human tissues","volume":"16","author":"Hikmet","year":"2020","journal-title":"Mol Syst Biol"},{"key":"B202","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41420-020-00307-w","article-title":"Digestive symptoms of COVID-19 and expression of ACE2 in digestive tract organs","volume":"6","author":"Xu","year":"2020","journal-title":"Cell Death Discovery"},{"key":"B203","doi-asserted-by":"publisher","first-page":"718136","DOI":"10.3389\/fimmu.2021.718136","article-title":"Preliminary evidence for IL-10-induced ACE2 mRNA expression in lung-derived and endothelial cells: implications for SARS-cov-2 ARDS pathogenesis","volume":"12","author":"Albini","year":"2021","journal-title":"Front Immunol"},{"key":"B204","doi-asserted-by":"publisher","first-page":"84","DOI":"10.18433\/jpps31455","article-title":"Epithelial and endothelial expressions of ACE2: SARS-coV-2 entry routes","volume":"24","author":"Guney","year":"2021","journal-title":"J Pharm Pharm Sci"},{"key":"B205","doi-asserted-by":"publisher","first-page":"103182","DOI":"10.1016\/j.ebiom.2020.103182","article-title":"SARS-CoV-2 leads to a small vessel endotheliitis in the heart","volume":"63","author":"Maccio","year":"2021","journal-title":"EBioMedicine"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.050754","article-title":"COVID-19-associated nonocclusive fibrin microthrombi in the heart","volume":"143","author":"Bois","year":"2021","journal-title":"Circulation"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N Engl J Med"},{"key":"B209","doi-asserted-by":"publisher","first-page":"2003147","DOI":"10.1183\/13993003.03147-2020","article-title":"Inflammation and intussusceptive angiogenesis in COVID-19: everything in and out of flow","volume":"56","author":"Ackermann","year":"2020","journal-title":"Eur Respir J"},{"key":"B210","doi-asserted-by":"publisher","first-page":"1076029620962853","DOI":"10.1177\/1076029620962853","article-title":"COVID-19 and hypercoagulability: A review","volume":"26","author":"Kichloo","year":"2020","journal-title":"Clin Appl Thromb Hemost"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.050354","article-title":"Severe COVID-19 is a microvascular disease","volume":"142","author":"Lowenstein","year":"2020","journal-title":"Circulation"},{"key":"B212","doi-asserted-by":"publisher","first-page":"104188","DOI":"10.1016\/j.mvr.2021.104188","article-title":"Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19)","volume":"137","author":"Norooznezhad","year":"2021","journal-title":"Microvasc Res"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007008","article-title":"Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome","volume":"136","author":"Middleton","year":"2020","journal-title":"Blood"},{"key":"B214","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.immuni.2019.04.003","article-title":"Inflammasome activation triggers blood clotting and host death through pyroptosis","volume":"50","author":"Wu","year":"2019","journal-title":"Immunity"},{"key":"B215","doi-asserted-by":"publisher","first-page":"916","DOI":"10.3390\/cells10040916","article-title":"Inflammasome activation-induced hypercoagulopathy: impact on cardiovascular dysfunction triggered in COVID-19 patients","volume":"10","author":"Gedefaw","year":"2021","journal-title":"Cells"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.117.309846","article-title":"Tissue factor: an essential mediator of hemostasis and trigger of thrombosis","volume":"38","author":"Grover","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1089\/dna.2021.0152","article-title":"IL-6 induction and signaling: horizons of COVID-19-related pathogenesis","volume":"40","author":"Patra","year":"2021","journal-title":"DNA Cell Biol"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007208","article-title":"Disseminated intravascular coagulation and its immune mechanisms","volume":"139","author":"Popescu","year":"2022","journal-title":"Blood"},{"key":"B219","doi-asserted-by":"publisher","first-page":"2002049","DOI":"10.1183\/13993003.02049-2020","article-title":"Pathogenesis of COVID-19-induced ARDS: implications for an ageing population","volume":"56","author":"Torres Acosta","year":"2020","journal-title":"Eur Respir J"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1159\/000520083","article-title":"Silent hypoxia in COVID-19: A case series","volume":"101","author":"Fuehner","year":"2022","journal-title":"Respiration"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1113\/JP280769","article-title":"Silent hypoxaemia in COVID-19 patients","volume":"599","author":"Simonson","year":"2021","journal-title":"J Physiol"},{"key":"B222","doi-asserted-by":"publisher","first-page":"e0262315","DOI":"10.1371\/journal.pone.0262315","article-title":"Observational study of changes in utilization and outcomes in mechanical ventilation in COVID-19","volume":"17","author":"Karagiannidis","year":"2022","journal-title":"PloS One"},{"key":"B223","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-coV-2 infections in engineered human tissues using clinical-grade soluble human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2020.12.026","article-title":"Progression from pneumonia to ARDS as a predictor for fatal COVID-19","volume":"14","author":"Hsu","year":"2021","journal-title":"J Infect Public Health"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.220449","article-title":"What are the long-term pulmonary sequelae of COVID-19 infection","volume":"304","author":"Elicker","year":"2022","journal-title":"Radiology"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06033-2","article-title":"COVID-19 pneumonia: different respiratory treatments for different phenotypes","volume":"46","author":"Gattinoni","year":"2020","journal-title":"Intensive Care Med"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00365-9","article-title":"Longitudinal respiratory subphenotypes in patients with COVID-19-related acute respiratory distress syndrome: results from three observational cohorts","volume":"9","author":"Bos","year":"2021","journal-title":"Lancet Respir Med"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202004-1226LE","article-title":"Respiratory mechanics of COVID-19- versus non-COVID-19-associated acute respiratory distress syndrome","volume":"202","author":"Haudebourg","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202008-1026OC","article-title":"COVID-19 versus non-COVID-19 acute respiratory distress syndrome: comparison of demographics, physiologic parameters, inflammatory biomarkers, and clinical outcomes","volume":"18","author":"Bain","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202004-1423LE","article-title":"COVID-19-related acute respiratory distress syndrome: not so atypical","volume":"202","author":"Bos","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1111\/his.14180","article-title":"Diffuse alveolar damage (DAD) resulting from coronavirus disease 2019 Infection is Morphologically Indistinguishable from Other Causes of DAD","volume":"77","author":"Konopka","year":"2020","journal-title":"Histopathology"},{"key":"B232","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with covid-19","volume":"384","author":"Group","year":"2021","journal-title":"N Engl J Med"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(19)30417-5","article-title":"Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial","volume":"8","author":"Villar","year":"2020","journal-title":"Lancet Respir Med"},{"key":"B234","doi-asserted-by":"publisher","first-page":"114909","DOI":"10.1016\/j.bcp.2022.114909","article-title":"Vascular endotheliitis associated with infections: Its pathogenetic role and therapeutic implication","volume":"197","author":"Hattori","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1159\/000518914","article-title":"Autopsy-based pulmonary and vascular pathology: pulmonary endotheliitis and multi-organ involvement in COVID-19 associated deaths","volume":"101","author":"Haberecker","year":"2022","journal-title":"Respiration"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.06.029","article-title":"The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management","volume":"194","author":"Abou-Ismail","year":"2020","journal-title":"Thromb Res"},{"key":"B237","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1056\/NEJMoa2105911","article-title":"Therapeutic anticoagulation with heparin in noncritically ill patients with covid-19","volume":"385","author":"Lawler","year":"2021","journal-title":"N Engl J Med"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(73)90036-1","article-title":"Collagen synthesis in thoracic aortas of rabbits with epinephrine-thyroxine induced arteriosclerosis","volume":"17","author":"Langner","year":"1973","journal-title":"Atherosclerosis"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0263580","article-title":"Incidence and prognostic value of pulmonary embolism in COVID-19: A systematic review and meta-analysis","volume":"17","author":"Gong","year":"2022","journal-title":"PloS One"},{"key":"B240","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3390\/biology11040520","article-title":"COVID-19-associated myocarditis: an evolving concern in cardiology and beyond","volume":"11","author":"Fraser","year":"2022","journal-title":"Biol (Basel)"},{"key":"B241","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.3390\/jcm10091974","article-title":"The spectrum of COVID-19-associated myocarditis: A patient-tailored multidisciplinary approach","volume":"10","author":"Peretto","year":"2021","journal-title":"J Clin Med"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2021.10.001","article-title":"COVID-19 associated myocarditis: A systematic review","volume":"51","author":"Haussner","year":"2022","journal-title":"Am J Emerg Med"},{"key":"B243","doi-asserted-by":"publisher","first-page":"498","DOI":"10.12691\/ajmcr-8-12-19","article-title":"Myocarditis associated with COVID-19","volume":"8","author":"Oleszak","year":"2020","journal-title":"Am J Med Case Rep"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7035e5","article-title":"Association between COVID-19 and myocarditis using hospital-based administrative data - United States, march 2020-january 2021","volume":"70","author":"Boehmer","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.1007\/s00414-020-02500-z","article-title":"SARS-Cov-2 fulminant myocarditis: an autopsy and histopathological case study","volume":"135","author":"Gauchotte","year":"2021","journal-title":"Int J Legal Med"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa160","article-title":"Evidence of SARS-CoV-2 mRNA in endomyocardial biopsies of patients with clinically suspected myocarditis tested negative for COVID-19 in nasopharyngeal swab","volume":"116","author":"Wenzel","year":"2020","journal-title":"Cardiovasc Res"},{"key":"B247","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S0140-6736(21)00896-5","article-title":"Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study","volume":"398","author":"Katsoularis","year":"2021","journal-title":"Lancet"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.2459\/JCM.0000000000001136","article-title":"Type 2 myocardial infarction in patients with coronavirus disease 2019","volume":"22","author":"Talanas","year":"2021","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.047525","article-title":"ST-elevation myocardial infarction in patients with COVID-19: clinical and angiographic outcomes","volume":"141","author":"Stefanini","year":"2020","journal-title":"Circulation"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.1101\/2022.01.31.478497","article-title":"Human cardiac organoids to model COVID-19 cytokine storm induced cardiac injuries","volume":"16","author":"Arhontoulis","year":"2022","journal-title":"bioRxiv"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10848-4","article-title":"Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions","volume":"269","author":"Beghi","year":"2022","journal-title":"J Neurol"},{"key":"B252","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.12131","article-title":"Global incidence of neurological manifestations among patients hospitalized with COVID-19-A report for the GCS-neuroCOVID consortium and the ENERGY consortium","volume":"4","author":"Chou","year":"2021","journal-title":"JAMA Netw Open"},{"key":"B253","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamaneurol.2020.2730","article-title":"Risk of ischemic stroke in patients with coronavirus disease 2019 (COVID-19) vs patients with influenza","volume":"77","author":"Merkler","year":"2020","journal-title":"JAMA Neurol"},{"key":"B254","doi-asserted-by":"publisher","first-page":"598272","DOI":"10.3389\/fmed.2020.598272","article-title":"Thirty-Day Mortality and Morbidity in COVID-19 Positive vs. COVID-19 Negative Individuals and vs. Individuals Tested for Influenza A\/B: A Population-Based Study","volume":"7","author":"Nersesjan","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(20)30287-X","article-title":"Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study","volume":"7","author":"Varatharaj","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"B256","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41398-021-01629-8","article-title":"Neuropsychiatric manifestations of COVID-19, potential neurotropic mechanisms, and therapeutic interventions","volume":"11","author":"Han","year":"2021","journal-title":"Transl Psychiatry"},{"key":"B257","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.immuni.2020.12.011","article-title":"Neurological manifestations of COVID-19 feature T cell exhaustion and dedifferentiated monocytes in cerebrospinal fluid","volume":"54","author":"Heming","year":"2021","journal-title":"Immunity"},{"key":"B258","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A6595","article-title":"Hemorrhagic posterior reversible encephalopathy syndrome as a manifestation of COVID-19 infection","volume":"41","author":"Franceschi","year":"2020","journal-title":"AJNR Am J Neuroradiol"},{"key":"B259","doi-asserted-by":"publisher","first-page":"583702","DOI":"10.3389\/fimmu.2020.583702","article-title":"Kidney failure associates with T cell exhaustion and imbalanced follicular helper T cells","volume":"11","author":"Hartzell","year":"2020","journal-title":"Front Immunol"},{"key":"B260","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfac174","article-title":"Immune responses to SARS-CoV-2 in dialysis and kidney transplantation","volume":"15","author":"Cantarelli","year":"2022","journal-title":"Clin Kidney J"},{"key":"B261","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2021020188","article-title":"Hemodialysis patients make long-lived antibodies against SARS-coV-2 that may be associated with reduced reinfection","volume":"32","author":"Banham","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"B262","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.03.009","article-title":"Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection","volume":"99","author":"Clarke","year":"2021","journal-title":"Kidney Int"},{"key":"B263","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2021121587","article-title":"SARS-coV-2-specific T cell responses are not associated with protection against reinfection in hemodialysis patients","volume":"33","author":"Shankar","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"B264","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41541-024-00886-0","article-title":"SARS-CoV-2-specific immune responses converge in kidney disease patients and controls with hybrid immunity","volume":"9","author":"Aguilar-Bretones","year":"2024","journal-title":"NPJ Vaccines"},{"key":"B265","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020030276","article-title":"Renal involvement and early prognosis in patients with COVID-19 pneumonia","volume":"31","author":"Pei","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"B266","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00011-021-01520-8","article-title":"Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies","volume":"71","author":"Faour","year":"2022","journal-title":"Inflammation Res"},{"key":"B267","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-021-00452-0","article-title":"Pathophysiology of COVID-19-associated acute kidney injury","volume":"17","author":"Legrand","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"B268","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfab303","article-title":"Acute kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK Study: a prospective, multicentre cohort study","volume":"37","author":"Sullivan","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"B269","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0242182","article-title":"Electronic health record analysis identifies kidney disease as the leading risk factor for hospitalization in confirmed COVID-19 patients","volume":"15","author":"Oetjens","year":"2020","journal-title":"PloS One"},{"key":"B270","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.07.015","article-title":"A multi-center retrospective cohort study defines the spectrum of kidney pathology in Coronavirus 2019 Disease (COVID-19)","volume":"100","author":"May","year":"2021","journal-title":"Kidney Int"},{"key":"B271","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2020.04.030","article-title":"COVID-19-associated collapsing glomerulopathy: an emerging entity","volume":"5","author":"Nasr","year":"2020","journal-title":"Kidney Int Rep"},{"key":"B272","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-022-00551-6","article-title":"Potential SARS-CoV-2 kidney infection and paths to injury","volume":"18","author":"Hassler","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"B273","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-020-0332-3","article-title":"COVAN is the new HIVAN: the re-emergence of collapsing glomerulopathy with COVID-19","volume":"16","author":"Velez","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"B274","doi-asserted-by":"publisher","first-page":"155826","DOI":"10.1016\/j.cyto.2022.155826","article-title":"SARS-CoV-2 infection causes intestinal cell damage: Role of interferon\u2019s imbalance","volume":"152","author":"Guimaraes Sousa","year":"2022","journal-title":"Cytokine"},{"key":"B275","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0817-4","article-title":"Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding","volume":"26","author":"Xu","year":"2020","journal-title":"Nat Med"},{"key":"B276","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13000-021-01082-7","article-title":"Case report: histopathology and molecular pathology analysis on enteric tissue of a COVID-19 patient","volume":"16","author":"Feng","year":"2021","journal-title":"Diagn Pathol"},{"key":"B277","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-coV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"B278","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc1669","article-title":"SARS-CoV-2 productively infects human gut enterocytes","volume":"369","author":"Lamers","year":"2020","journal-title":"Science"},{"key":"B279","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.3390\/cells11071103","article-title":"Neutrophil extracellular traps in severe SARS-coV-2 infection: A possible impact of LPS and (1\u2013>3)-beta-D-glucan in blood from gut translocation","volume":"11","author":"Saithong","year":"2022","journal-title":"Cells"},{"key":"B280","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009306","article-title":"Preexisting and inducible endotoxemia as crucial contributors to the severity of COVID-19 outcomes","volume":"17","author":"Kruglikov","year":"2021","journal-title":"PloS Pathog"},{"key":"B281","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12916-021-02212-0","article-title":"Gut microbiome alterations and gut barrier dysfunction are associated with host immune homeostasis in COVID-19 patients","volume":"20","author":"Sun","year":"2022","journal-title":"BMC Med"},{"key":"B282","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-022-00698-4","article-title":"Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications","volume":"20","author":"Zhang","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B283","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac136","article-title":"Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: A meta-analysis and systematic review","volume":"226","author":"Chen","year":"2022","journal-title":"J Infect Dis"},{"key":"B284","doi-asserted-by":"publisher","first-page":"n693","DOI":"10.1136\/bmj.n693","article-title":"Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study","volume":"372","author":"Ayoubkhani","year":"2021","journal-title":"BMJ"},{"key":"B285","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","article-title":"Multiple early factors anticipate post-acute COVID-19 sequelae","volume":"185","author":"Su","year":"2022","journal-title":"Cell"},{"key":"B286","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.28568","article-title":"Short-term and long-term rates of postacute sequelae of SARS-coV-2 infection: A systematic review","volume":"4","author":"Groff","year":"2021","journal-title":"JAMA Netw Open"},{"key":"B287","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02156-9","article-title":"Comorbidities, multimorbidity and COVID-19","volume":"29","author":"Russell","year":"2023","journal-title":"Nat Med"},{"key":"B288","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41586-023-06651-y","article-title":"Distinguishing features of Long COVID identified through immune profiling","volume":"623","author":"Klein","year":"2023","journal-title":"Nature"},{"key":"B289","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05542-y","article-title":"SARS-CoV-2 infection and persistence in the human body and brain at autopsy","volume":"612","author":"Stein","year":"2022","journal-title":"Nature"},{"key":"B290","doi-asserted-by":"publisher","DOI":"10.1101\/2022.06.14.22276401","article-title":"Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae","volume":"76","author":"Swank","year":"2022","journal-title":"Clin Infect Dis"},{"key":"B291","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-022-01052-6","article-title":"Long Covid: where we stand and challenges ahead","volume":"29","author":"Mantovani","year":"2022","journal-title":"Cell Death Differ"},{"key":"B292","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-023-00896-0","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"B293","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001687","article-title":"Why does viral RNA sometimes persist after recovery from acute infections","volume":"20","author":"Griffin","year":"2022","journal-title":"PloS Biol"},{"key":"B294","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.548156","article-title":"Viral persistence in the myocardium is associated with progressive cardiac dysfunction","volume":"112","author":"Kuhl","year":"2005","journal-title":"Circulation"},{"key":"B295","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3390\/pathogens10060763","article-title":"Investigation of long COVID prevalence and its relationship to epstein-barr virus reactivation","volume":"10","author":"Gold","year":"2021","journal-title":"Pathogens"},{"key":"B296","doi-asserted-by":"publisher","first-page":"199157","DOI":"10.1016\/j.virusres.2023.199157","article-title":"Incidence of Epstein-Barr virus reactivation is elevated in COVID-19 patients","volume":"334","author":"Bernal","year":"2023","journal-title":"Virus Res"},{"key":"B297","doi-asserted-by":"publisher","first-page":"921101","DOI":"10.3389\/fmed.2022.921101","article-title":"Revisiting igG antibody reactivity to epstein-barr virus in myalgic encephalomyelitis\/chronic fatigue syndrome and its potential application to disease diagnosis","volume":"9","author":"Sepulveda","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B298","doi-asserted-by":"publisher","first-page":"1234785","DOI":"10.3389\/fimmu.2023.1234785","article-title":"The impact of the COVID-19 pandemic on the global tuberculosis epidemic","volume":"14","author":"Falzon","year":"2023","journal-title":"Front Immunol"},{"key":"B299","doi-asserted-by":"publisher","first-page":"e45989","DOI":"10.7759\/cureus.45989","article-title":"Clinical and immunological impacts of latent toxoplasmosis on COVID-19 patients","volume":"15","author":"Habib","year":"2023","journal-title":"Cureus"},{"key":"B300","doi-asserted-by":"publisher","first-page":"7570981","DOI":"10.1155\/2020\/7570981","article-title":"Circulating cytokines and lymphocyte subsets in patients who have recovered from COVID-19","volume":"2020","author":"Hasichaolu","year":"2020","journal-title":"BioMed Res Int"},{"key":"B301","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01113-x","article-title":"Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection","volume":"23","author":"Phetsouphanh","year":"2022","journal-title":"Nat Immunol"},{"key":"B302","doi-asserted-by":"publisher","first-page":"100663","DOI":"10.1016\/j.xcrm.2022.100663","article-title":"The IL-1beta, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19","volume":"3","author":"Schultheiss","year":"2022","journal-title":"Cell Rep Med"},{"key":"B303","doi-asserted-by":"publisher","first-page":"1011936","DOI":"10.3389\/fmed.2023.1011936","article-title":"A review of cytokine-based pathophysiology of Long COVID symptoms","volume":"10","author":"Low","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"B304","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.cytogfr.2021.06.002","article-title":"The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies","volume":"61","author":"Zhao","year":"2021","journal-title":"Cytokine Growth Factor Rev"},{"key":"B305","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.autrev.2018.01.020","article-title":"NLRP3: A promising therapeutic target for autoimmune diseases","volume":"17","author":"Shen","year":"2018","journal-title":"Autoimmun Rev"},{"key":"B306","doi-asserted-by":"publisher","first-page":"104299","DOI":"10.1016\/j.ebiom.2022.104299","article-title":"Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications","volume":"85","author":"Potere","year":"2022","journal-title":"EBioMedicine"},{"key":"B307","doi-asserted-by":"publisher","first-page":"1185233","DOI":"10.3389\/fimmu.2023.1185233","article-title":"Inflammasomes: a rising star on the horizon of COVID-19 pathophysiology","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"key":"B308","doi-asserted-by":"publisher","first-page":"5417","DOI":"10.1038\/s41467-021-25509-3","article-title":"New-onset IgG autoantibodies in hospitalized patients with COVID-19","volume":"12","author":"Chang","year":"2021","journal-title":"Nat Commun"},{"key":"B309","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"B310","doi-asserted-by":"publisher","DOI":"10.1172\/JCI161167","article-title":"Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches","volume":"132","author":"Ahamed","year":"2022","journal-title":"J Clin Invest"},{"key":"B311","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1038\/s41467-020-17292-4","article-title":"Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia","volume":"11","author":"De Biasi","year":"2020","journal-title":"Nat Commun"},{"key":"B312","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1887722","article-title":"Integrated gut virome and bacteriome dynamics in COVID-19 patients","volume":"13","author":"Cao","year":"2021","journal-title":"Gut Microbes"},{"key":"B313","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-022-02263-w","article-title":"Multisystem inflammatory syndrome in children (MIS-C) and neonates (MIS-N) associated with COVID-19: optimizing definition and management","volume":"93","author":"Molloy","year":"2023","journal-title":"Pediatr Res"},{"key":"B314","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.05.050","article-title":"Multisystem inflammatory syndrome in adults: A rare sequela of SARS-CoV-2 infection","volume":"108","author":"Ahmad","year":"2021","journal-title":"Int J Infect Dis"},{"key":"B315","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6932e2","article-title":"COVID-19-associated multisystem inflammatory syndrome in children - United States, march-july 2020","volume":"69","author":"Godfred-Cato","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B316","unstructured":""},{"key":"B317","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.01.054","article-title":"Multisystem inflammatory syndrome in children and adults (MIS-C\/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data","volume":"39","author":"Vogel","year":"2021","journal-title":"Vaccine"},{"key":"B318","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-020-03766-6","article-title":"Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach","volume":"180","author":"Sperotto","year":"2021","journal-title":"Eur J Pediatr"},{"key":"B319","doi-asserted-by":"publisher","first-page":"ytab470","DOI":"10.1093\/ehjcr\/ytab470","article-title":"Multisystem inflammatory syndrome in adults (MIS-A) associated with SARS-CoV-2 infection with delayed-onset myocarditis: case report","volume":"5","author":"Shen","year":"2021","journal-title":"Eur Heart J Case Rep"},{"key":"B320","doi-asserted-by":"publisher","first-page":"ytab521","DOI":"10.1093\/ehjcr\/ytab521","article-title":"Multisystem inflammatory syndrome in adults in a young male following severe acute respiratory syndrome coronavirus-2 infection: a case report","volume":"6","author":"Kaufmann","year":"2022","journal-title":"Eur Heart J Case Rep"},{"key":"B321","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000000630","article-title":"Clinical and histopathologic features of myocarditis in multisystem inflammatory syndrome (Adult)-associated COVID-19","volume":"10","author":"Aldeghaither","year":"2022","journal-title":"Crit Care Explor"},{"key":"B322","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.35089","article-title":"Use of the postacute sequelae of COVID-19 diagnosis code in routine clinical practice in the US","volume":"5","author":"McGrath","year":"2022","journal-title":"JAMA Netw Open"},{"key":"B323","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2023.0750","article-title":"Risk factors associated with post-COVID-19 condition: A systematic review and meta-analysis","volume":"183","author":"Tsampasian","year":"2023","journal-title":"JAMA Intern Med"},{"key":"B324","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01689-3","article-title":"Long-term cardiovascular outcomes of COVID-19","volume":"28","author":"Xie","year":"2022","journal-title":"Nat Med"},{"key":"B325","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvac195","article-title":"Association of COVID-19 with short- and long-term risk of cardiovascular disease and mortality: a prospective cohort in UK Biobank","volume":"119","author":"Wan","year":"2023","journal-title":"Cardiovasc Res"},{"key":"B326","doi-asserted-by":"publisher","DOI":"10.1038\/s44161-023-00220-2","article-title":"Excess cardiovascular mortality across multiple COVID-19 waves in the United States from March 2020 to March 2022","volume":"2","author":"Han","year":"2023","journal-title":"Nat Cardiovasc Res"},{"key":"B327","doi-asserted-by":"publisher","first-page":"n1098","DOI":"10.1136\/bmj.n1098","article-title":"Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study","volume":"373","author":"Daugherty","year":"2021","journal-title":"BMJ"},{"key":"B328","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.2411","article-title":"The COVID heart-one year after SARS-coV-2 infection, patients have an array of increased cardiovascular risks","volume":"327","author":"Abbasi","year":"2022","journal-title":"JAMA"},{"key":"B329","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3390\/jpm12020162","article-title":"Long-term prognostic impact of right ventricular dysfunction in patients with COVID-19","volume":"12","author":"Scudiero","year":"2022","journal-title":"J Pers Med"},{"key":"B330","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s12931-020-01570-2","article-title":"Pulmonary hypertension secondary to pulmonary fibrosis: clinical data, histopathology and molecular insights","volume":"21","author":"Ruffenach","year":"2020","journal-title":"Respir Res"},{"key":"B331","doi-asserted-by":"publisher","first-page":"5S","DOI":"10.1016\/j.jacc.2004.02.037","article-title":"Clinical classification of pulmonary hypertension","volume":"43","author":"Simonneau","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"B332","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2014.07.003","article-title":"The post-PE syndrome: a new concept for chronic complications of pulmonary embolism","volume":"28","author":"Klok","year":"2014","journal-title":"Blood Rev"},{"key":"B333","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.212170","article-title":"Quantitative chest CT assessment of small airways disease in post-acute SARS-coV-2 infection","volume":"304","author":"Cho","year":"2022","journal-title":"Radiology"},{"key":"B334","doi-asserted-by":"publisher","first-page":"101079","DOI":"10.1016\/j.eclinm.2021.101079","article-title":"COVID-19 and the effects on pulmonary function following infection: A retrospective analysis","volume":"39","author":"Lewis","year":"2021","journal-title":"EClinicalMedicine"},{"key":"B335","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12931-022-01994-y","article-title":"One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study","volume":"23","author":"Faverio","year":"2022","journal-title":"Respir Res"},{"key":"B336","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2021-001049","article-title":"Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID)","volume":"8","author":"Wild","year":"2021","journal-title":"BMJ Open Respir Res"},{"key":"B337","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.3390\/jcm10112452","article-title":"Post-COVID-19 pulmonary fibrosis: novel sequelae of the current pandemic","volume":"10","author":"Ambardar","year":"2021","journal-title":"J Clin Med"},{"key":"B338","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcaa255","article-title":"Post-COVID-19 pneumonia pulmonary fibrosis","volume":"113","author":"Tale","year":"2020","journal-title":"QJM"},{"key":"B339","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03569-1","article-title":"A molecular single-cell lung atlas of lethal COVID-19","volume":"595","author":"Melms","year":"2021","journal-title":"Nature"},{"key":"B340","doi-asserted-by":"publisher","first-page":"1013526","DOI":"10.3389\/fcimb.2022.1013526","article-title":"Pulmonary fibrosis in patients with COVID-19: A retrospective study","volume":"12","author":"Li","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B341","doi-asserted-by":"publisher","first-page":"101019","DOI":"10.1016\/j.eclinm.2021.101019","article-title":"Characterizing long COVID in an international cohort: 7 months of symptoms and their impact","volume":"38","author":"Davis","year":"2021","journal-title":"EClinicalMedicine"},{"key":"B342","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/j.pain.0000000000002711","article-title":"A comparison of pain, fatigue, and function between post-COVID-19 condition, fibromyalgia, and chronic fatigue syndrome: a survey study","volume":"164","author":"Haider","year":"2023","journal-title":"Pain"},{"key":"B343","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-055164","article-title":"Brain MRI and neuropsychological findings at long-term follow-up after COVID-19 hospitalisation: an observational cohort study","volume":"11","author":"Hellgren","year":"2021","journal-title":"BMJ Open"},{"key":"B344","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02001-z","article-title":"Long-term neurologic outcomes of COVID-19","volume":"28","author":"Xu","year":"2022","journal-title":"Nat Med"},{"key":"B345","doi-asserted-by":"publisher","DOI":"10.1126\/science.abm2052","article-title":"Nervous system consequences of COVID-19","volume":"375","author":"Spudich","year":"2022","journal-title":"Science"},{"key":"B346","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06651-y","article-title":"Distinguishing features of long COVID identified through immune profiling","volume":"623","author":"Klein","year":"2023","journal-title":"Nature"},{"key":"B347","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1016\/j.cell.2023.09.013","article-title":"Serotonin reduction in post-acute sequelae of viral infection","volume":"186","author":"Wong","year":"2023","journal-title":"Cell"},{"key":"B348","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200097","article-title":"Deep phenotyping of neurologic postacute sequelae of SARS-coV-2 infection","volume":"10","author":"Mina","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B349","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-061245","article-title":"COVID-19 postacute care major organ damage: a systematic review","volume":"12","author":"Greer","year":"2022","journal-title":"BMJ Open"},{"key":"B350","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03553-9","article-title":"High-dimensional characterization of post-acute sequelae of COVID-19","volume":"594","author":"Al-Aly","year":"2021","journal-title":"Nature"},{"key":"B351","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V391541","article-title":"Infectious morbidity and defects of phagocytic function in end-stage renal disease: a review","volume":"3","author":"Vanholder","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"B352","doi-asserted-by":"publisher","DOI":"10.1053\/j.jrn.2011.10.020","article-title":"Effect of uremia on structure and function of immune system","volume":"22","author":"Vaziri","year":"2012","journal-title":"J Ren Nutr"},{"key":"B353","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002019","article-title":"Spontaneous leukocyte activation and oxygen-free radical generation in end-stage renal disease","volume":"71","author":"Yoon","year":"2007","journal-title":"Kidney Int"},{"key":"B354","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41392-022-01036-5","article-title":"Signaling pathways of chronic kidney diseases, implications for therapeutics","volume":"7","author":"Yuan","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B355","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10238-007-0127-x","article-title":"Decreased antigen-specific T-cell proliferation by moDC among hepatitis B vaccine non-responders on haemodialysis","volume":"7","author":"Verkade","year":"2007","journal-title":"Clin Exp Med"},{"key":"B356","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-023-03528-x","article-title":"Long-term interplay between COVID-19 and chronic kidney disease","volume":"55","author":"Schiffl","year":"2023","journal-title":"Int Urol Nephrol"},{"key":"B357","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-020-00790-5","article-title":"Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry","volume":"33","author":"Uribarri","year":"2020","journal-title":"J Nephrol"},{"key":"B358","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2011.379","article-title":"Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis","volume":"81","author":"Coca","year":"2012","journal-title":"Kidney Int"},{"key":"B359","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2020.01.011","article-title":"Pathophysiology of AKI to CKD progression","volume":"40","author":"Sato","year":"2020","journal-title":"Semin Nephrol"},{"key":"B360","doi-asserted-by":"publisher","DOI":"10.1172\/JCI72267","article-title":"Cellular and molecular mechanisms in kidney fibrosis","volume":"124","author":"Duffield","year":"2014","journal-title":"J Clin Invest"},{"key":"B361","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2144","article-title":"Epithelial cell cycle arrest in G2\/M mediates kidney fibrosis after injury","volume":"16","author":"Yang","year":"2010","journal-title":"Nat Med"},{"key":"B362","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.stem.2014.11.004","article-title":"Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis","volume":"16","author":"Kramann","year":"2015","journal-title":"Cell Stem Cell"},{"key":"B363","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241534","article-title":"Kidney ACE2 expression: Implications for chronic kidney disease","volume":"15","author":"Maksimowski","year":"2020","journal-title":"PloS One"},{"key":"B364","doi-asserted-by":"publisher","first-page":"700220","DOI":"10.3389\/fphys.2021.700220","article-title":"Angiotensin-converting enzyme 2 in the pathogenesis of renal abnormalities observed in COVID-19 patients","volume":"12","author":"Azinheira Nobrega Cruz","year":"2021","journal-title":"Front Physiol"},{"key":"B365","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12882-021-02490-z","article-title":"Chronic kidney disease linked to SARS-CoV-2 infection: a case report","volume":"22","author":"Tarris","year":"2021","journal-title":"BMC Nephrol"},{"key":"B366","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab914","article-title":"Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: The Hamburg City Health Study COVID programme","volume":"43","author":"Petersen","year":"2022","journal-title":"Eur Heart J"},{"key":"B367","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01283-z","article-title":"Post-acute COVID-19 syndrome","volume":"27","author":"Nalbandian","year":"2021","journal-title":"Nat Med"},{"key":"B368","doi-asserted-by":"publisher","first-page":"bqab203","DOI":"10.1210\/endocr\/bqab203","article-title":"Impact of COVID-19 on the endocrine system: A mini-review","volume":"163","author":"Clarke","year":"2022","journal-title":"Endocrinology"},{"key":"B369","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2020.09.020","article-title":"Analysis of sex hormones and menstruation in COVID-19 women of child-bearing age","volume":"42","author":"Li","year":"2021","journal-title":"Reprod BioMed Online"},{"key":"B370","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-022-01616-9","article-title":"Long-term implications of COVID-19 on bone health: pathophysiology and therapeutics","volume":"71","author":"Sapra","year":"2022","journal-title":"Inflammation Res"},{"key":"B371","doi-asserted-by":"publisher","first-page":"102883","DOI":"10.1016\/j.autrev.2021.102883","article-title":"Rheumatological complications of covid 19","volume":"20","author":"Zacharias","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B372","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1136\/annrheumdis-2020-217573","article-title":"Myositis as a manifestation of SARS-coV-2","volume":"80","author":"Beydon","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"B373","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.10.005","article-title":"Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review","volume":"28","author":"Fiolet","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"B374","doi-asserted-by":"publisher","DOI":"10.1007\/s11596-021-2395-1","article-title":"A comprehensive review of COVID-19 virology, vaccines, variants, and therapeutics","volume":"41","author":"Forchette","year":"2021","journal-title":"Curr Med Sci"},{"key":"B375","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3390\/life12020170","article-title":"SARS-coV-2 variants and clinical outcomes: A systematic review","volume":"12","author":"Mendiola-Pastrana","year":"2022","journal-title":"Life (Basel)"},{"key":"B376","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3390\/idr14030052","article-title":"COVID-19 variants in critically ill patients: A comparison of the delta and omicron variant profiles","volume":"14","author":"Corriero","year":"2022","journal-title":"Infect Dis Rep"},{"key":"B377","doi-asserted-by":"publisher","first-page":"16010","DOI":"10.3390\/ijerph192316010","article-title":"Comparison of long COVID-19 caused by different SARS-coV-2 strains: A systematic review and meta-analysis","volume":"19","author":"Du","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B378","doi-asserted-by":"publisher","first-page":"101624","DOI":"10.1016\/j.eclinm.2022.101624","article-title":"Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review","volume":"53","author":"Notarte","year":"2022","journal-title":"EClinicalMedicine"},{"key":"B379","doi-asserted-by":"publisher","first-page":"e000385","DOI":"10.1136\/bmjmed-2022-000385","article-title":"Effect of covid-19 vaccination on long covid: systematic review","volume":"2","author":"Byambasuren","year":"2023","journal-title":"BMJ Med"},{"key":"B380","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abo0732","article-title":"Differential proinflammatory activities of Spike proteins of SARS-CoV-2 variants of concern","volume":"8","author":"Tyrkalska","year":"2022","journal-title":"Sci Adv"},{"key":"B381","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvab339","article-title":"Prolonged endothelial-dysfunction in human arterioles following infection with SARS-CoV-2","volume":"118","author":"Nishijima","year":"2022","journal-title":"Cardiovasc Res"},{"key":"B382","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvad006","article-title":"Differential impacts of COVID-19 variants on human microvascular function","volume":"119","author":"Nishijima","year":"2023","journal-title":"Cardiovasc Res"},{"key":"B383","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.59272","article-title":"Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy","volume":"18","author":"Jiang","year":"2022","journal-title":"Int J Biol Sci"},{"key":"B384","doi-asserted-by":"publisher","DOI":"10.1002\/art.41285","article-title":"On the alert for cytokine storm: immunopathology in COVID-19","volume":"72","author":"Henderson","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"B385","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa449","article-title":"Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) is closely correlated with drastically elevated interleukin 6 level in critically ill patients with coronavirus disease 2019","volume":"71","author":"Chen","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B386","doi-asserted-by":"publisher","first-page":"155507","DOI":"10.1016\/j.cyto.2021.155507","article-title":"IL-6 and IL-10 are associated with disease severity and higher comorbidity in adults with COVID-19","volume":"143","author":"Luporini","year":"2021","journal-title":"Cytokine"},{"key":"B387","doi-asserted-by":"publisher","first-page":"737406","DOI":"10.3389\/fimmu.2021.737406","article-title":"IL-7 in SARS-coV-2 infection and as a potential vaccine adjuvant","volume":"12","author":"Bekele","year":"2021","journal-title":"Front Immunol"},{"key":"B388","doi-asserted-by":"publisher","first-page":"626235","DOI":"10.3389\/fimmu.2021.626235","article-title":"High levels of circulating IL-8 and soluble IL-2R are associated with prolonged illness in patients with severe COVID-19","volume":"12","author":"Ma","year":"2021","journal-title":"Front Immunol"},{"key":"B389","doi-asserted-by":"publisher","first-page":"5104","DOI":"10.1038\/s41467-022-32507-6","article-title":"A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity","volume":"13","author":"Kedor","year":"2022","journal-title":"Nat Commun"},{"key":"B390","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.10.004","article-title":"Interleukin-22 in human inflammatory diseases and viral infections","volume":"16","author":"Shabgah","year":"2017","journal-title":"Autoimmun Rev"},{"key":"B391","doi-asserted-by":"publisher","first-page":"951107","DOI":"10.3389\/fimmu.2022.951107","article-title":"The role of interleukin-22 in lung health and its therapeutic potential for COVID-19","volume":"13","author":"Fang","year":"2022","journal-title":"Front Immunol"},{"key":"B392","doi-asserted-by":"publisher","DOI":"10.1126\/science.8009221","article-title":"Functional role of type I and type II interferons in antiviral defense","volume":"264","author":"Muller","year":"1994","journal-title":"Science"},{"key":"B393","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00429-3","article-title":"The type I interferon response in COVID-19: implications for treatment","volume":"20","author":"Lee","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B394","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.cell.2020.11.025","article-title":"Synergism of TNF-alpha and IFN-gamma triggers inflammatory cell death, tissue damage, and mortality in SARS-coV-2 infection and cytokine shock syndromes","volume":"184","author":"Karki","year":"2021","journal-title":"Cell"},{"key":"B395","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501209","article-title":"Age-associated B cells: A T-bet-dependent effector with roles in protective and pathogenic immunity","volume":"195","author":"Rubtsova","year":"2015","journal-title":"J Immunol"},{"key":"B396","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1038\/s41467-021-22210-3","article-title":"SARS-CoV-2 in severe COVID-19 induces a TGF-beta-dominated chronic immune response that does not target itself","volume":"12","author":"Ferreira-Gomes","year":"2021","journal-title":"Nat Commun"},{"key":"B397","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41586-021-04142-6","article-title":"Untimely TGFbeta responses in COVID-19 limit antiviral functions of NK cells","volume":"600","author":"Witkowski","year":"2021","journal-title":"Nature"},{"key":"B398","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0944-y","article-title":"A single-cell atlas of the peripheral immune response in patients with severe COVID-19","volume":"26","author":"Wilk","year":"2020","journal-title":"Nat Med"},{"key":"B399","doi-asserted-by":"publisher","DOI":"10.1101\/2020.08.27.20182550","article-title":"MAIT cell activation and dynamics associated with COVID-19 disease severity","volume":"5","author":"Parrot","year":"2020","journal-title":"Sci Immunol"},{"key":"B400","doi-asserted-by":"publisher","first-page":"e09230","DOI":"10.1016\/j.heliyon.2022.e09230","article-title":"Severe COVID-19 is characterised by inflammation and immature myeloid cells early in disease progression","volume":"8","author":"Townsend","year":"2022","journal-title":"Heliyon"},{"key":"B401","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abo5795","article-title":"A persistent neutrophil-associated immune signature characterizes post-COVID-19 pulmonary sequelae","volume":"14","author":"George","year":"2022","journal-title":"Sci Transl Med"},{"key":"B402","doi-asserted-by":"publisher","first-page":"838011","DOI":"10.3389\/fimmu.2022.838011","article-title":"NETosis and neutrophil extracellular traps in COVID-19: immunothrombosis and beyond","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Immunol"},{"key":"B403","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244855","article-title":"Switched and unswitched memory B cells detected during SARS-CoV-2 convalescence correlate with limited symptom duration","volume":"16","author":"Newell","year":"2021","journal-title":"PloS One"},{"key":"B404","doi-asserted-by":"publisher","first-page":"152136","DOI":"10.1016\/j.imbio.2021.152136","article-title":"MBL deficiency-causing B allele (rs1800450) as a risk factor for severe COVID-19","volume":"226","author":"Speletas","year":"2021","journal-title":"Immunobiology"},{"key":"B405","doi-asserted-by":"publisher","first-page":"104959","DOI":"10.1016\/j.isci.2022.104959","article-title":"SARS-CoV-2-specific CD4(+) T cell longevity correlates with Th17-like phenotype","volume":"25","author":"Terahara","year":"2022","journal-title":"iScience"},{"key":"B406","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12916-021-02228-6","article-title":"Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection","volume":"20","author":"Ryan","year":"2022","journal-title":"BMC Med"},{"key":"B407","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(22)00036-2","article-title":"SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study","volume":"3","author":"Guo","year":"2022","journal-title":"Lancet Microbe"},{"key":"B408","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24064","article-title":"Hematological changes associated with COVID-19 infection","volume":"36","author":"Al-Saadi","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"B409","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25829","article-title":"Hematological findings and complications of COVID-19","volume":"95","author":"Terpos","year":"2020","journal-title":"Am J Hematol"},{"key":"B410","doi-asserted-by":"publisher","first-page":"102695","DOI":"10.1016\/j.autrev.2020.102695","article-title":"SARS-CoV-2, the autoimmune virus","volume":"19","author":"Halpert","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B411","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12933-021-01359-7","article-title":"Persistent clotting protein pathology in Long COVID\/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin","volume":"20","author":"Pretorius","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"B412","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003349","article-title":"Incidence of symptomatic, image-confirmed venous thromboembolism following hospitalization for COVID-19 with 90-day follow-up","volume":"4","author":"Salisbury","year":"2020","journal-title":"Blood Adv"},{"key":"B413","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s42399-022-01167-4","article-title":"Post-acute sequelae of COVID-19 (PASC): a meta-narrative review of pathophysiology, prevalence, and management","volume":"4","author":"Munipalli","year":"2022","journal-title":"SN Compr Clin Med"},{"key":"B414","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/s12882-021-02557-x","article-title":"COVID-19-related acute kidney injury; incidence, risk factors and outcomes in a large UK cohort","volume":"22","author":"Jewell","year":"2021","journal-title":"BMC Nephrol"},{"key":"B415","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-022-00925-y","article-title":"Unbiased discovery of autoantibodies associated with severe COVID-19 via genome-scale self-assembled DNA-barcoded protein libraries","volume":"6","author":"Credle","year":"2022","journal-title":"Nat Biomed Eng"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1376654\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T07:28:57Z","timestamp":1739345337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1376654\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":415,"alternative-id":["10.3389\/fimmu.2024.1376654"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1376654","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,12]]},"article-number":"1376654"}}